Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00994422 · ClinicalTrials.gov registry record · Phase 2
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
A Phase 2 study of Head Lice, sponsored by Topaz Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 264
- Enrollment target
- 12
- Study locations
NCT00994422 is a Phase 2 study of Head Lice that has completed, run by Topaz Pharmaceuticals. The registered enrollment target is 264 participants, above the 64-participant average among 5 other Head Lice trials with a reported enrollment target (313% higher). The trial reports 12 study locations across 10 states.
The verdict
NCT00994422, a Phase 2 study of Head Lice, has completed, sponsored by Topaz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 264 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this study is to compare the safety and efficacy of a 0.5% ivermectin cream to a placebo in subjects infested with head lice when used in an "at home" environment.
Conditions Studied
Interventions
- DRUG Ivermectin cream
- DRUG vehicle control
Study Locations (12)
Florida
- Lice Cleanique, LLC - Delray Beach
- Hill-Top Research Corp - St. Petersburg
- LSRN - West Palm Beach
Arizona
- Cactus Kids Pediatrics - Yuma
California
- Impact Clinical Trials - Los Angeles
Minnesota
- Minnesota Clinical Study Center - Fridley
New Mexico
- Lovelace Scientific Resources, Inc. - Albuquerque
North Carolina
- Haywood Pediatric Adolescent Medicine Group, PA - Clyde
Ohio
- Hill Top Research Corp. - Miamiville
Tennessee
- LSRN - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2009-10 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00994422
The ClinicalTrials.gov registry entry for NCT00994422 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 64-participant average among 5 other Head Lice trials with a reported enrollment target (313% higher). The listed sponsor is Topaz Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which Ivermectin cream is the first listed.
NCT00994422 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT00994422 about?
NCT00994422 is a clinical study titled "Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects". The purpose of this study is to compare the safety and efficacy of a 0.5% ivermectin cream to a placebo in subjects infested with head lice when used in an "at home" environment.
What is the current status of trial NCT00994422?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 264 participants. The study started on 2009-10. Estimated completion is 2009-12.
What conditions does trial NCT00994422 study?
This clinical trial studies the following conditions: Head Lice.
What interventions are being tested in trial NCT00994422?
The interventions under investigation include: Ivermectin cream (DRUG), vehicle control (DRUG).
Who is sponsoring clinical trial NCT00994422?
This trial is sponsored by Topaz Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00994422 being conducted?
This trial has 12 study locations across Arizona, California, Florida, Minnesota, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Lice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pediatric Head Lice Study Product Comparison
COMPLETED · Phase 2
-
A Pilot Dose Ranging Study of Spinosad Creme Rinse
COMPLETED · Phase 2
-
Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo
RECRUITING · NA
-
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
COMPLETED · NA
-
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.